ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

DDDD 4d Pharma Plc

16.36
0.00 (0.00%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
4d Pharma Plc LSE:DDDD London Ordinary Share GB00BJL5BR07 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 16.36 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

4d Pharma Share Discussion Threads

Showing 18626 to 18649 of 39350 messages
Chat Pages: Latest  746  745  744  743  742  741  740  739  738  737  736  735  Older
DateSubjectAuthorDiscuss
19/2/2021
09:56
Appreciate if someone can post the link to Duncan's latest presentation.
frrinvest
19/2/2021
09:49
Moderator and the other young lady.
vanduke
19/2/2021
09:47
It may be an age thing? Or where you live? I personally thought Duncan was far more relatable and trust worthy! Much more impressed than the other two!
f3rdinand
19/2/2021
09:47
Jonathan Soloman may have something to say about that.
gtaval1
19/2/2021
09:45
Errr. . . and he should wear a bowler hat G to prove he's British I suppose.
John

2350220
19/2/2021
09:44
Considering the other two people on the call were female, making the assumption they shaved and ironed their shirts is simply rude.;-)
vanduke
19/2/2021
09:42
I did this morning. The other guys on the call looked considerably smarter and sounded more convincing despite the fact they had nothing to offer compared to 4D.
5070481
19/2/2021
09:37
“Paralyze resistance with persistence”

FYI

Yourgene Health. Whispers Contract/s "Done Deal".....

Dan
x

daniel levi bmd
19/2/2021
09:35
5070481, if you believe that, why don't you then?
zydecoco
19/2/2021
09:31
Would be great for someone to message Duncan and tell him that when he is on video representing a company he hopes to turn into a multi billion enterprise, that he should shave and iron a shirt. Whether he likes it or not, raising finance is a sales job. Better appearance adn sharper delivery is require.
5070481
19/2/2021
09:30
yes, he did, he is a trader as much as an investor!
devonlad
19/2/2021
09:12
RG buys in 10 k blocks Been selling on Dnl for ages Didn't he sell and then started buying back ?
s34icknote
19/2/2021
09:10
When 140 goes it should fast track toward 200..
rjcdc
19/2/2021
08:54
LOL is Umar Kamani in the market ?
the stigologist
19/2/2021
08:51
For info. one of the late reported after hours trades yesterday was a single Buy of just over £183,000 of shares, transacted just before noon
ambyth
19/2/2021
08:36
Looks like our 10k buyer is back today
shrewdmole
19/2/2021
08:32
Thank you so much for the synopsis someuwin.
Great stuff.
John

2350220
19/2/2021
08:29
Let the board member who used to be a microbiologist (Alex) do the technical conferences. If Biomx and Synlogic are putting that style of delivery then that is what US investors like to hear at these events. If they want to be drowned in science you can do no harm in drowning them.

I recall last year both Alex and Duncan spoke at the Chardan conference, will be interesting to see how they line up for this and the other 2 March events.

theweatherman1
19/2/2021
08:28
Duncan was asked what was happening this year?, and thats what he answered in terms of.
ambyth
19/2/2021
08:26
Watching yesterday's webinar, it was clear to see how more advance we are when compared to our peers.
vanduke
19/2/2021
08:22
I did wonder whether the american investors would be able to understand the geordie accent.
1airbag
19/2/2021
08:20
Don't ramble for over a minute about things which aren't going to move the needle. I'd have mentioned one major financial milestone Nasdaq uplist and 2/3 major and imminent milestones like cancer trial data. Pointless mentioning non core Asthma due in H2
the stigologist
19/2/2021
08:19
I actually prefer Duncans presentation approach.Was a bit sceptical initially but it's a natural, detailed based non BS approach.Basically, don't need to over sell it as the science and proceeding muti bill $ valuation will do the talking!!
vanduke
19/2/2021
08:13
re...Duncan could do with getting more succinct and snappy with his Elevator Pitch for new investors


What do you suggest?;)

thefartingcommie
Chat Pages: Latest  746  745  744  743  742  741  740  739  738  737  736  735  Older

Your Recent History

Delayed Upgrade Clock